However, it was reported that dialysis patients with diabetes and malnutrition–inflammation–atherosclerosis syndrome had significantly higher leptin levels and required higher erythropoietin dose; indeed, erythropoietin dosage was associated significantly with levels of leptin and biomarkers of inflammation [102]. The gene discussed is EPO; the disease is diabetes mellitus.